Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

13.00
+0.08000.62%
Post-market: 13.00-0.0100-0.08%16:22 EDT
Volume:1.34M
Turnover:17.50M
Market Cap:1.12B
PE:-3.49
High:13.59
Open:13.35
Low:12.81
Close:12.92
Loading ...

Promising 2025 Outlook for Syndax Pharmaceuticals: Strategic Product Launches and Expansion Plans Drive Buy Recommendation

TIPRANKS
·
23 Jan

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
16 Jan

Incyte, Syndax Receive FDA Approval for Niktimvo to Treat Chronic Graft-Versus-Host Disease

MT Newswires Live
·
16 Jan

Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes

Dow Jones
·
16 Jan

Incyte, Syndax announce FDA approval for Niktimvo vial sizes

TIPRANKS
·
16 Jan

BRIEF-Incyte And Syndax Announce U.S. Food And Drug Administration (FDA) Approval Of Niktimvo™ (Axatilimab-Csfr) 9 mg And 22 mg Vial Sizes

Reuters
·
16 Jan

Incyte Corp - Niktimvo Expected to Be Available in U.S. in Early February

THOMSON REUTERS
·
16 Jan

Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (Axatilimab-Csfr) 9 Mg and 22 Mg Vial Sizes

THOMSON REUTERS
·
16 Jan

Syndax Pharmaceuticals (SNDX) Gets a Buy from Bank of America Securities

TIPRANKS
·
15 Jan

Investing in Syndax Pharmaceuticals (NASDAQ:SNDX) five years ago would have delivered you a 53% gain

Simply Wall St.
·
10 Jan

Barclays Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
08 Jan

BRIEF-Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Jan

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
04 Jan

Syndax Pharmaceuticals Restructures Leadership Team

TIPRANKS
·
21 Dec 2024

BRIEF-Syndax Pharmaceuticals Inc - Eliminates Chief Medical Officer Position

Reuters
·
21 Dec 2024

Syndax Pharmaceuticals Inc - Catherine Madigan to Cease as Chief Medical Officer

THOMSON REUTERS
·
21 Dec 2024

Barclays Gives a Buy Rating to Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
19 Dec 2024

U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart

Reuters
·
17 Dec 2024

Health Rounds: New combination treatments promising for blood cancers

Reuters
·
11 Dec 2024

Syndax Pharmaceuticals (SNDX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
10 Dec 2024